We support reimbursement and market access strategy from the earliest stages of development, helping MedTech innovators understand market realities, anticipate reimbursement risk, and prioritize the pathways that enable access and adoption.
Coverage, Coding, & Payment AssessmentCoding, coverage, and payment assessments clarify reimbursement pathways by evaluating existing coverage policies, applicability of current codes, payment mechanisms, and strategic considerations—helping teams anticipate barriers, mitigate risk, and plan proactively.
Market Opportunity AssessmentMarket opportunity assessments evaluate the clinical, health economic, and medical device reimbursement landscape to help innovators understand where demand exists, how stakeholders make decisions, and which markets offer the strongest potential for sustainable market access.
Life Sciences Expert Advisory PanelLife Sciences Expert Advisory Panel brings together payer, provider, and industry expertise to validate assumptions, pressure‑test strategy, and inform reimbursement planning with real‑world perspectives.
Once the reimbursement strategy is defined, IQVIA MedTech supports execution across the activities that turn planning into market access. Our teams help operationalize reimbursement pathways, engage stakeholders, and move strategies forward with clarity and momentum.
Coding & Payment Applications
Coding and payment application support helps innovators prepare and submit high‑quality documentation that reflects clinical value, economic impact, and real‑world use—supporting informed MedTech reimbursement decisions.
Patient Access Programs
Patient access programs generate insights into utilization, patient experience, and access dynamics—supporting evidence needs while facilitating early patient access where appropriate.
Payer Engagement
Payer engagement services provide structured interactions with Medical Directors and policy committee members to support coverage strategy. Our team gathers feedback, refines value narratives, and aligns evidence generation with payer expectations.
Real‑World Evidence (RWE)
Real‑world evidence services leverage observational data, analytics, and real‑world insights to demonstrate device performance in practice, supporting your medical device reimbursement strategy, market access, and long‑term value.
